Q1 2015 Holdings
Filed 2015-05-15 | 64 holdings | $278.1K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-05-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $22.6K | 100,000 | 8.1% |
| Zimmer Hldgs Inc(ZBH) | COM | 98956P102 | $11.8K | 100,000 | 4.2% |
| Actavis PLC | SHS | G0083B108 | $10.4K | 35,000 | 3.7% |
| Endo Health Solutions Inc | NOTE 1.750% 4/1 | 29264FAB2 | $8.1K | 90,000 | 2.9% |
| Community Health SYS Inc New(CYH) | COM | 203668108 | $7.8K | 150,000 | 2.8% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $7.4K | 160,000 | 2.6% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.1K | 30,000 | 2.5% |
| ZS Pharma Inc | COM | 98979G105 | $6.9K | 165,000 | 2.5% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $6.9K | 225,000 | 2.5% |
| Celgene Corp(CELG) | COM | 151020104 | $6.9K | 60,000 | 2.5% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $6.8K | 180,000 | 2.5% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.0K | 120,000 | 2.2% |
| Dyax Corp | COM | 26746E103 | $5.9K | 350,000 | 2.1% |
| Merit MED SYS Inc(MMSI) | COM | 589889104 | $5.8K | 300,000 | 2.1% |
| Merck & Co Inc New(MRK) | COM | 58933Y105 | $5.7K | 100,000 | 2.1% |
| Wright MED Group Inc | COM | 98235T107 | $5.2K | 200,000 | 1.9% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $5.0K | 35,000 | 1.8% |
| Genocea Biosciences Inc | COM | 372427104 | $5.0K | 420,000 | 1.8% |
| Nuvasive Inc(NUVAGBP)Call | COM | 670704105 | $4.6K | 100,000 | 1.7% |
| Alcobra LTD | SHS | M2239P109 | $4.5K | 800,000 | 1.6% |
| Avalanche Biotechnologies in | COM | 05337G107 | $4.5K | 110,000 | 1.6% |
| Biomarin Pharmaceutical Inc(BMRN)A | COM | 09061G101 | $4.4K | 35,000 | 1.6% |
| Sunesis Pharmaceuticals Inc | COM NEW | 867328601 | $4.3K | 1,750,000 | 1.5% |
| Cepheid | COM | 15670R107 | $4.3K | 75,000 | 1.5% |
| Alnylam Pharmaceuticals Inc(ALNY)A | COM | 02043Q107 | $4.2K | 40,000 | 1.5% |
| Agilent Technologies Inc(A)Call | COM | 00846U101 | $4.2K | 100,000 | 1.5% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $4.1K | 200,000 | 1.5% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $4.1K | 45,000 | 1.5% |
| Abbvie Inc(ABBV)A | COM | 00287Y109 | $4.1K | 70,000 | 1.5% |
| Avalanche Biotechnologies inCall | COM | 05337G107 | $4.1K | 100,000 | 1.5% |
| Acadia Pharmaceuticals Inc(ACAD)A | COM | 004225108 | $3.9K | 120,000 | 1.4% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $3.9K | 120,000 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $3.9K | 175,000 | 1.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $3.8K | 350,000 | 1.4% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $3.7K | 375,000 | 1.3% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $3.7K | 60,000 | 1.3% |
| Therapeuticsmd Inc | COM | 88338N107 | $3.6K | 600,000 | 1.3% |
| Bluebird BIO Inc | COM | 09609G100 | $3.6K | 30,000 | 1.3% |
| Flamel Technologies SA | SPONSORED ADR | 338488109 | $3.6K | 200,000 | 1.3% |
| Inogen Inc(INGN) | COM | 45780L104 | $3.5K | 110,000 | 1.3% |
| Vitae Pharmaceuticals Inc | COM | 92847N103 | $3.5K | 300,000 | 1.3% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $3.5K | 150,000 | 1.3% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $3.4K | 335,000 | 1.2% |
| Entellus MED Inc | COM | 29363K105 | $3.3K | 150,000 | 1.2% |
| Radius Health Inc | COM NEW | 750469207 | $3.1K | 75,000 | 1.1% |
| Discovery Laboratories Inc N | COM NEW | 254668403 | $3.0K | 2,500,000 | 1.1% |
| Pernix Therapeutics Hldgs in | COM | 71426V108 | $2.7K | 250,000 | 1.0% |
| Ignyta Inc | COM | 451731103 | $2.5K | 250,000 | 0.9% |
| Lion Biotechnologies Inc | COM | 53619R102 | $2.4K | 200,000 | 0.9% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $2.4K | 65,000 | 0.9% |